Imaging Industry Expands Emerging Market Focus
This article was originally published in The Gray Sheet
Executive Summary
A recent award from the U.S. Commerce Department comes at an opportune time for the imaging and radiation therapy industry to accelerate its push for regulatory reforms in China and India, says the sector’s top lobbyist.
You may also be interested in...
MITA, AdvaMed Pair Up To Urge Chinese Adoption Of Updated Device Standards
Many countries have already transitioned to the latest edition of the International Engineering Consortium's electromedical equipment standard, but China is one of the last major holdouts, industry reps say.
AdvaMed Delegates Go To China; Business Ethics Code In The Works
AdvaMed and Chinese device makers agreed to harmonize China's standards for ethical business practices with AdvaMed's code of ethics and other international policies in a memorandum of understanding signed earlier this month
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”